IMMUCELL CORP /DE/ Quarterly Common Stock, Shares Authorized from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Immucell Corp /De/ quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q2 2024.
  • Immucell Corp /De/ Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 15M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 15M 0 0% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 15M 0 0% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 15M 0 0% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 15M 0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 15M 0 0% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 15M 0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 15M 0 0% Dec 31, 2022 10-K 2024-04-01
Q3 2022 15M 0 0% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 15M 0 0% Jun 30, 2022 10-Q/A 2022-11-21
Q1 2022 15M 0 0% Mar 31, 2022 10-Q/A 2022-11-21
Q4 2021 15M 0 0% Dec 31, 2021 10-K 2023-03-29
Q3 2021 15M 0 0% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 15M 0 0% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 15M +4M +36.4% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 15M +4M +36.4% Dec 31, 2020 10-K 2022-03-30
Q3 2020 15M +4M +36.4% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 15M +4M +36.4% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 11M 0 0% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 11M 0 0% Dec 31, 2019 10-K 2021-03-30
Q3 2019 11M 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 11M 0 0% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 11M +3M +37.5% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 11M +3M +37.5% Dec 31, 2018 10-K 2020-03-27
Q3 2018 11M +3M +37.5% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 11M +3M +37.5% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 8M -2M -20% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 8M 0 0% Dec 31, 2017 10-K 2019-03-22
Q3 2017 8M -2M -20% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 8M -2M -20% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 10M +2M +25% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 8M 0 0% Dec 31, 2016 10-K 2018-03-29
Q3 2016 10M +2M +25% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 10M +2M +25% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 8M 0 0% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 8M 0 0% Dec 31, 2015 10-K 2017-03-30
Q3 2015 8M 0 0% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 8M 0 0% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 8M 0 0% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 8M 0 0% Dec 31, 2014 10-K 2016-03-25
Q3 2014 8M 0 0% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 8M 0 0% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 8M 0 0% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 8M 0 0% Dec 31, 2013 10-K 2015-03-26
Q3 2013 8M 0 0% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 8M 0 0% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 8M 0 0% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 8M 0 0% Dec 31, 2012 10-K 2014-03-26
Q3 2012 8M 0 0% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 8M 0 0% Jun 30, 2012 10-Q/A 2012-09-07
Q1 2012 8M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 8M 0 0% Dec 31, 2011 10-K 2013-03-28
Q3 2011 8M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 8M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 8M Dec 31, 2010 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.